% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Srinivasan:128367,
author = {H. Srinivasan$^*$ and Y. Allory and M. Sill$^*$ and D.
Vordos and M. S. S. Alhamdani$^*$ and F. Radvanyi and J.
Hoheisel$^*$ and C. Schröder$^*$},
title = {{P}rediction of recurrence of non muscle-invasive bladder
cancer by means of a protein signature identified by
antibody microarray analyses.},
journal = {Practical proteomics},
volume = {14},
number = {11},
issn = {1615-9853},
address = {Weinheim},
publisher = {Wiley VCH55771},
reportid = {DKFZ-2017-04384},
pages = {1333 - 1342},
year = {2014},
abstract = {About $70\%$ of newly diagnosed cases of bladder cancer are
low-stage, low-grade, non muscle-invasive. Standard
treatment is transurethral resection. About $60\%$ of the
tumors will recur, however, and in part progress to become
invasive. Therefore, surveillance cystoscopy is performed
after resection. However, in the USA and Europe alone, about
54 000 new patients per year undergo repeated cystoscopies
over several years, who do not experience recurrence.
Analysing in a pilot study resected tumors from patients
with (n = 19) and without local recurrence (n = 6) after a
period of 5 years by means of an antibody microarray that
targeted 724 cancer-related proteins, we identified 255
proteins with significantly differential abundance. Most are
involved in the regulation and execution of apoptosis and
cell proliferation. A multivariate classifier was
constructed based on 20 proteins. It facilitates the
prediction of recurrence with a sensitivity of $80\%$ and a
specificity of $100\%.$ As a measure of overall accuracy,
the area under the curve value was found to be $91\%.$ After
validation in additional sample cohorts with a similarly
long follow-up, such a signature could support decision
making about the stringency of surveillance or even
different treatment options.},
keywords = {Proteome (NLM Chemicals)},
cin = {C060 / B070},
ddc = {540},
cid = {I:(DE-He78)C060-20160331 / I:(DE-He78)B070-20160331},
pnm = {312 - Functional and structural genomics (POF3-312)},
pid = {G:(DE-HGF)POF3-312},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:24610664},
doi = {10.1002/pmic.201300320},
url = {https://inrepo02.dkfz.de/record/128367},
}